Comments
Loading...

OncoCyte

OCXNASDAQ
Logo brought to you by Benzinga Data
$2.08
-0.02-0.95%
At close: -
$2.33
0.2512.02%
After Hours: Jan 7, 5:01 PM EDT

OncoCyte (NASDAQ:OCX) Stock, Earnings Estimates, EPS, And Revenue

OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Apr 11
EPS Estimate
$0.000
Quarterly Revenue Estimate
$101.67K
Annual Revenue
(as of Sep 30)
$709.00K

Analyze the earnings history of OncoCyte using advanced sorting and filters.

Data brought to you by Benzinga APIs

OncoCyte (OCX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-12$-0.41$-0.446.82 %
Q22024-08-08$-0.36$-0.5635.7 %
Q12024-05-15$-1.13$-0.67-68.7 %
Q42024-04-12$-2.18$-1.14-91.2 %

OncoCyte (OCX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-12$115.00K$200.00K-42.5 %
Q22024-08-08$104.00K$320.00K-67.5 %
Q12024-05-15$176.00K$350.00K-49.7 %
Q42024-04-12$314.00K$320.00K-1.88 %

FAQ

Q

When is OncoCyte (NASDAQ:OCX) reporting earnings?

A

OncoCyte (OCX) is scheduled to report earnings on April 11, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for OncoCyte (NASDAQ:OCX)?

A

The Actual EPS was $-0.41, which beat the estimate of $-0.44.

Q

What were OncoCyte’s (NASDAQ:OCX) revenues?

A

The Actual Revenue was $115K, which missed the estimate of $200K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch